Commercial Opportunities of Today & the Future

By Brian G. Kelly Ph.D.

Published: April, 2003

250+ Pages 90+ Tables & Exhibits 45+ Companies Profiled  

The market value for chiral platform technologies will be $2.7 billion by 2007 - an average annual growth rate of 10.8%.

The niche field of chiral technologies is responsible for exciting new breakthroughs that have hugely impacted the routes to discovery and the means of production of pharmaceuticals and other chemical compounds, such as agrochemicals and flavor/fragrance compounds. Improved therapeutic activity, a reduced amount of side effects, and the requirements of regulatory groups points to the vast majority of new pharmaceutical products being 'chiral'. Other factors serving to drive the growth of the chiral technologies industry are the consolidation and outsourcing practices within companies and the "biotech revolution." 

D&MD expects to see considerable growth in the use of chiral products-particularly in the sales of chiral drugs in the areas of oncology, respiratory, and central nervous system. We also expect substantial growth in certain agrochemical applications, and in flavor and fragrance compounds. 

D&MD's Chiral Technologies Market Analysis Report provides a thorough review of this promising industry. This Report will help you: 

Discover the commercial viability of chiral technology platforms through a detailed breakdown of their widespread uses and applications 

Identify future growth areas for chiral intermediates with a complete breakdown of the market and a quantification of their end-uses 

Pinpoint the full market potential of chiral end-products- including pharmaceuticals, agrochemicals, and fragrance & flavor chemicals-through a comprehensive analysis of the market statistics, therapeutic areas, chemical structures, and identification of "hot" areas for currently marketed products and future products already in the pipeline 

Gain a thorough understanding of today's market via a discussion and instructive case studies of the various business models, strategies, and issues which impinge on the chiral technologies industry  

Focus on potential lucrative ventures from an identification of market segments that have yet to be fully exploited and which present significant commercial opportunities 

Look inside more than 45 companies working within the chirals industry, including their product pipelines, alliances, business strategies, and more 

This Report will prove beneficial to:

Individuals responsible for Research & Development, Business & Corporate Development, and Planning within the following industry sectors:  

Pharmaceutical, Fine Chemicals, Agrochemicals, Flavor/Fragrance, Chiral Technology Companies, Venture Capital/Investment Banking. 

In addition to Directors, Analysts, Professors of Chemistry & Biochemistry, Business & Corporate Development within government agencies, management consulting firms, universities, and laboratory equipment suppliers.

Publisher: Drug and Market Development 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a75